Urology Cancer Center — Omaha, Nebraska

Urology Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Urology Cancer Center has participated in 5 clinical trials.

Therapeutic areas: Prostate Cancer, Prostate Cancer Metastatic, Castration-resistant Prostate Cancer.

Sponsors: Sun Pharmaceutical Industries Limited, Eli Lilly and Company, Innocrin Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Urology Cancer Center?

Urology Cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Urology Cancer Center conducted?

Urology Cancer Center has 5 clinical trials on record. Their work covers Prostate Cancer, Prostate Cancer Metastatic, Castration-resistant Prostate Cancer.

Is Urology Cancer Center accredited by Crixeo Health?

Urology Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Urology Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.